Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of botulinum toxin for scar prevention
IRCT20180826040876N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Jul 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of neuronox in severe cutaneous adverse reactions (SCAR), sponsored by Tehran University of Medical Sciences. Started Jul 2018; status: completed.
02
Drugs
neuronox
03
Conditions
severe cutaneous adverse reactions (SCAR)
Beyond the preview
Go deeper on IRCT20180826040876N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180826040876N1.